{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":79,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":79,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"5ec910aabd7a","filters":{"venue":"Anti-Cancer Drugs"}},"results":[{"id":"W2325764269","doi":"10.1097/00001813-200303000-00008","title":"Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Doxorubicin; Pharmacokinetics; Metastatic breast cancer; Liposome; Medicine; Breast cancer; Pharmacology; Cyclophosphamide; Cancer; Chemotherapy; Chemistry; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01314134033673586,"gpt":0.2877310070471609,"spread":0.2745896667104251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000320213,0.0006421889,0.001309061,0.0005451621,0.00009951096,0.00003194855,0.0002099981,0.0001234585,0.001462747],"category_scores_gemma":[0.000009755715,0.0004899518,0.0000974587,0.001263164,0.0003759203,0.0003105756,0.00003344801,0.0005789226,0.00001129541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006095382,"about_ca_system_score_gemma":0.0009603845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005905055,"about_ca_topic_score_gemma":0.001986487,"domain_scores_codex":[0.996392,0.0003516279,0.0009223951,0.0007345309,0.0008557682,0.0007437002],"domain_scores_gemma":[0.9980496,0.0001326426,0.0006299334,0.000365686,0.0005616494,0.0002605067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01516791,0.006114461,0.9590454,0.0005915101,0.001359163,0.0001458505,0.003121013,0.001619462,0.01095325,0.0001658703,0.0007498182,0.0009662953],"study_design_scores_gemma":[0.09384657,0.003499583,0.8102924,0.001850132,0.001342121,0.00005578797,0.0008411884,0.0003255169,0.08630624,0.0001121325,0.0007402237,0.000788075],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943651,0.0006865193,0.00002347492,0.001064731,0.0002088244,0.002279535,0.0003336559,0.00005171781,0.000986435],"genre_scores_gemma":[0.9966899,0.0004160871,0.0003780544,0.0007871914,0.0000408304,0.0003609398,0.0004418482,0.0001008196,0.0007843322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.148753,"threshold_uncertainty_score":0.9997552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966425626","doi":"10.1097/00001813-200311000-00001","title":"Doxycycline and other tetracyclines in the treatment of bone metastasis","year":2003,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Bone health and treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Doxycycline; Prostate cancer; Cancer research; Medicine; Matrix metalloproteinase; Metastasis; Breast cancer; Tetracycline; Cancer; Cancer cell; Osteoclast; Minocycline; Bone metastasis; Matrix metalloproteinase inhibitor; Oncology; Internal medicine; Biology; Antibiotics; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.09369714820908856,"gpt":0.4241381933555619,"spread":0.3304410451464733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002330769,0.0004271127,0.002381176,0.0002171767,0.00004530221,0.000009695358,0.00006408947,0.0001852347,0.0001013042],"category_scores_gemma":[0.00001257854,0.0002178645,0.0003741584,0.0004110345,0.00009842428,0.00002909089,0.000008423603,0.0001681135,0.00001781015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001171836,"about_ca_system_score_gemma":0.0002765818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001701575,"about_ca_topic_score_gemma":0.0002100584,"domain_scores_codex":[0.9980608,0.0001749717,0.0008105054,0.0003915279,0.000236219,0.0003260113],"domain_scores_gemma":[0.9988136,0.0002035268,0.0003723506,0.0004725757,0.00003146581,0.0001065408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002393782,0.001150644,0.002255866,0.006307789,0.0004511766,0.00004013262,0.000323908,4.051509e-8,2.436359e-7,0.0000245322,0.0002317312,0.98919],"study_design_scores_gemma":[0.002062151,0.0003081133,0.0003167363,0.003602162,0.002685997,0.00006131442,0.00005572487,4.977744e-7,0.00001011468,0.00001024564,0.9907359,0.0001510833],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003250836,0.9936129,4.088462e-7,0.0002820887,0.0001395929,0.001613726,0.0002043308,0.00001179731,0.0008842758],"genre_scores_gemma":[0.0004744521,0.9969805,0.0001720391,0.0005042263,0.00009780619,0.0003869415,0.00005725079,0.00005216866,0.001274578],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9905041,"threshold_uncertainty_score":0.8884255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978585178","doi":"10.1097/00001813-200606000-00014","title":"Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Doxorubicin; Cardiotoxicity; Anthracycline; Internal medicine; Metastatic breast cancer; Cyclophosphamide; Breast cancer; Adjuvant; Randomization; Oncology; Cancer; Chemotherapy; Surgery; Randomized controlled trial; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.008634561448113807,"gpt":0.2784867038953679,"spread":0.2698521424472541,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006150993,0.0006639788,0.003225038,0.001144217,0.00007354261,0.00001108643,0.0001758902,0.000122436,0.0001500764],"category_scores_gemma":[0.00003543459,0.000490363,0.0004094731,0.002897575,0.0004653504,0.0001717,0.00003847442,0.0002384838,7.823703e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001315325,"about_ca_system_score_gemma":0.001044976,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.07132562,"about_ca_topic_score_gemma":0.03148451,"domain_scores_codex":[0.9955103,0.0005300015,0.001696232,0.0009573392,0.0006584344,0.0006476608],"domain_scores_gemma":[0.9963832,0.0004088945,0.001495668,0.0005860655,0.0009412841,0.0001849081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.153958,0.005867637,0.7333685,0.0002370539,0.004023517,0.0000989336,0.001176645,0.008109841,0.09275468,0.000001447989,0.00003979685,0.000363938],"study_design_scores_gemma":[0.06380585,0.003879565,0.7123325,0.0008166271,0.003361436,0.000006069903,0.0001577527,0.004594277,0.210715,0.000002581919,0.00001188686,0.0003163976],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921418,0.0004980911,0.00002928437,0.0004458914,0.00008272074,0.002792476,0.003918416,0.0000255296,0.00006575514],"genre_scores_gemma":[0.9980925,0.0004481512,0.0002264272,0.00005219192,0.00005322729,0.0003291974,0.0005140632,0.00006097591,0.000223223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1179603,"threshold_uncertainty_score":0.9997548,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055722183","doi":"10.1097/00001813-200503000-00009","title":"Enhancement of antineoplastic action of 5-aza-2???-deoxycytidine by zebularine on L1210 leukemia","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Deoxycytidine; Cancer research; Decitabine; In vivo; Leukemia; L1210 cells; DNA methylation; Biology; Molecular biology; Chemistry; In vitro; Cytotoxicity; Gene; Immunology; Cancer; Gene expression; Biochemistry; Gemcitabine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01103043741581199,"gpt":0.2846017155389284,"spread":0.2735712781231164,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001394779,0.0001489365,0.0002119178,0.000051501,0.00003422833,0.000005573866,0.0001171241,0.0001111473,0.00008406624],"category_scores_gemma":[0.00002533413,0.0001443931,0.00008134648,0.0001015606,0.00005644892,0.000005353076,0.00004816406,0.00007022503,0.000007243524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000380288,"about_ca_system_score_gemma":0.00008393633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001130785,"about_ca_topic_score_gemma":0.00002206749,"domain_scores_codex":[0.9989793,0.00002935424,0.0003344551,0.0002760009,0.0002015949,0.0001793435],"domain_scores_gemma":[0.9993076,0.0000159906,0.0002419244,0.0002737658,0.000114987,0.00004574345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008613794,0.0001217794,0.002018739,0.00004624328,0.00005308165,9.341321e-8,0.0000358306,0.0009091577,0.9817271,0.00002668696,0.001183919,0.01379127],"study_design_scores_gemma":[0.0006832309,0.0003189654,0.001937501,0.00003648363,0.00002648607,1.94681e-7,0.00001780982,0.0002810463,0.9680893,0.00001147204,0.02845826,0.0001392641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951169,0.001497547,0.002005508,0.000168627,0.0001553754,0.0001364995,0.00004107372,0.000005762734,0.0008726483],"genre_scores_gemma":[0.9943212,0.003797935,0.0003701427,0.00007370482,0.0002806355,0.00001333356,0.0001342469,0.00001998533,0.0009888342],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02727434,"threshold_uncertainty_score":0.5888178,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984697909","doi":"10.1097/cad.0b013e3282a213ce","title":"Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Micropharma (Canada)","funders":"National Institute of Allergy and Infectious Diseases; Korea Research Institute of Standards and Science","keywords":"Doxorubicin; Internalization; Cancer research; Cytotoxicity; In vitro; In vivo; Pharmacology; Cancer cell; Liposome; Chemistry; Medicine; Cancer; Cell; Chemotherapy; Biology; Biochemistry; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.008670695760990747,"gpt":0.2795823270588681,"spread":0.2709116312978774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003772841,0.0001761087,0.0004342354,0.0004695924,0.00006133555,0.0000322263,0.00005505229,0.00009264203,0.00006567188],"category_scores_gemma":[0.00004042327,0.0001615606,0.00006524766,0.0004403369,0.00008080475,0.0002070359,0.00005799361,0.0001701801,0.000005873951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005195271,"about_ca_system_score_gemma":0.00003417426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002970795,"about_ca_topic_score_gemma":0.00006085783,"domain_scores_codex":[0.9986637,0.00004558455,0.00041381,0.0003125431,0.0002841892,0.0002801605],"domain_scores_gemma":[0.9993925,0.00008681751,0.0001928915,0.0001216406,0.00007874478,0.0001274204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006787445,0.00008956778,0.0819784,0.0005216594,0.00005030173,0.00005557734,0.000850122,0.00001197466,0.9142233,0.00006695224,0.0001026946,0.001981556],"study_design_scores_gemma":[0.00215884,0.00006643993,0.04020889,0.003472638,0.00008764963,0.00001226418,0.0003133701,0.001900788,0.9514681,0.00001209866,0.000133141,0.0001658182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974228,0.001084885,0.0005766223,0.0001850374,0.00006694627,0.0002226191,0.00001303086,0.00003183811,0.0003961932],"genre_scores_gemma":[0.9983382,0.0006745811,0.000181026,0.0002926949,0.0001105656,0.000004870534,0.00002045663,0.00002251833,0.0003550966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0417695,"threshold_uncertainty_score":0.658825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2328178778","doi":"10.1097/cad.0000000000000132","title":"Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro","year":2014,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"Government of Jiangsu Province","keywords":"Curcumin; Apoptosis; Mitochondrion; Glycolysis; Hexokinase; Cell biology; Cancer research; Protein kinase B; Intrinsic apoptosis; Anaerobic glycolysis; Chemistry; Cancer cell; Biology; Biochemistry; Programmed cell death; Metabolism; Cancer; Caspase; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.007410755609613626,"gpt":0.250974849820372,"spread":0.2435640942107584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001897332,0.0003630374,0.000564385,0.0001600285,0.000157119,0.00004477137,0.0002377698,0.0003297487,0.00004800863],"category_scores_gemma":[0.00003803104,0.0003716123,0.0001176496,0.0004496205,0.0001948486,0.00003060811,0.0002142501,0.0002580192,0.000003921281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007177565,"about_ca_system_score_gemma":0.0001672525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00566969,"about_ca_topic_score_gemma":0.002802185,"domain_scores_codex":[0.9978089,0.0001409323,0.0004576963,0.0007980356,0.0002143547,0.0005800787],"domain_scores_gemma":[0.9992782,0.00002867103,0.0001925087,0.0003032907,0.00007548906,0.0001218531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001871467,0.0001494129,0.0009394662,0.00004276784,0.00005267036,5.182671e-7,0.0009922358,0.00005626557,0.9922101,0.00001165448,0.001711557,0.003646206],"study_design_scores_gemma":[0.002861585,0.000100586,0.001690344,0.0000696195,0.00004845087,0.000001004682,0.0001784909,0.00002844922,0.9542093,0.00002280108,0.0403439,0.000445445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931203,0.004624286,0.00001201296,0.0002574756,0.001159344,0.0004411452,0.0001102996,0.00001981694,0.000255364],"genre_scores_gemma":[0.9906325,0.006412217,0.0001408608,0.0006012962,0.00137993,0.000337162,0.0001427944,0.00005096671,0.0003022199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03863235,"threshold_uncertainty_score":0.9998736,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326174046","doi":"10.1097/cad.0000000000000212","title":"Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals","year":2015,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Medical Research Group","funders":"Genentech","keywords":"Erlotinib; Ranitidine; Pharmacology; Cmax; Pharmacokinetics; Medicine; Omeprazole; Erlotinib Hydrochloride; Tolerability; Proton-pump inhibitor; Gastroenterology; Internal medicine; Epidermal growth factor receptor; Adverse effect; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02399015545910215,"gpt":0.3935949706607426,"spread":0.3696048152016404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002835515,0.0001506256,0.0003741932,0.0001997578,0.0000224843,0.000006393474,0.00006834394,0.0000488672,0.00007636345],"category_scores_gemma":[0.00003572667,0.0001149024,0.00006108616,0.000409405,0.00004280419,0.00004891102,0.00001967249,0.0001426691,0.00003478049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001975721,"about_ca_system_score_gemma":0.0003059739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004677031,"about_ca_topic_score_gemma":0.000009453898,"domain_scores_codex":[0.9988673,0.00008144862,0.000265216,0.0002187134,0.0003185529,0.0002487299],"domain_scores_gemma":[0.9993569,0.0001057789,0.0001168433,0.0001854962,0.0000714157,0.0001635282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002125894,0.001315087,0.8336638,0.0006828684,0.0004878767,0.00004004101,0.004802644,0.0006285629,0.002264169,0.0001330734,0.01860338,0.1352526],"study_design_scores_gemma":[0.152624,0.0334853,0.3347448,0.002675028,0.003368186,0.00005439904,0.001316635,0.0007382549,0.3673508,0.0001547948,0.1022669,0.001221058],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99075,0.00127406,0.000007060883,0.001350414,0.000340268,0.0007233305,0.00005935462,0.00002961973,0.005465894],"genre_scores_gemma":[0.997718,0.0005374657,0.0001000371,0.0008980071,0.0001567742,0.0001029686,0.00004051892,0.00002328058,0.0004229138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.498919,"threshold_uncertainty_score":0.4685584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2315916150","doi":"10.1097/00001813-200209000-00013","title":"Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cancer research; Clonogenic assay; Histone deacetylase; Acetylation; Phenylbutyrate; Histone; Carcinogenesis; DNA methylation; Chemistry; Trichostatin A; Gene silencing; Lung cancer; Biology; Molecular biology; DNA; Cell; Gene expression; Biochemistry; Gene; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03047106055752515,"gpt":0.2963949783436929,"spread":0.2659239177861678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008402357,0.0001456472,0.0001628691,0.0000553941,0.00008724378,0.00001523675,0.00007573807,0.0001029893,0.00005027295],"category_scores_gemma":[0.000009901881,0.000142434,0.00005353108,0.00007878432,0.00006297581,0.000005071371,0.00004177423,0.00006966865,0.000005185945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001082358,"about_ca_system_score_gemma":0.0000121378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007807142,"about_ca_topic_score_gemma":0.00001867779,"domain_scores_codex":[0.9991608,0.0000363794,0.0002024039,0.0002998568,0.000121366,0.0001791425],"domain_scores_gemma":[0.9995154,0.00001405006,0.0001319561,0.0002162302,0.00006639052,0.0000559989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001638398,0.0001261794,0.01109238,0.00005417317,0.00002667789,6.491088e-7,0.00008502647,0.00009463033,0.985669,0.00003349964,0.0004040067,0.00239746],"study_design_scores_gemma":[0.001053304,0.0001887721,0.01146078,0.00002282509,0.00003052456,4.616214e-7,0.00002924648,0.0008822,0.9840984,0.00001718665,0.002055374,0.0001609107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961061,0.002261971,0.0001614137,0.0000687504,0.0001845614,0.0001180878,0.00002717645,0.0000081195,0.001063758],"genre_scores_gemma":[0.9958898,0.002799168,0.00006203102,0.00005390648,0.0002314421,0.000008799998,0.00002971532,0.00002197416,0.0009031366],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002236549,"threshold_uncertainty_score":0.5808289,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963819705","doi":"10.1097/cad.0b013e328341185b","title":"Inhibiting aberrant Stat3 function with molecular therapeutics","year":2010,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada); University of Toronto","funders":"","keywords":"STAT3; STAT protein; Cancer research; Downregulation and upregulation; Biology; Multiple myeloma; Signal transduction; Cell biology; Immunology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.04739348485247957,"gpt":0.3524562118507138,"spread":0.3050627269982342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001490216,0.0004674408,0.001279662,0.000208809,0.0001289531,0.00006053025,0.000105314,0.0002923137,0.0003885795],"category_scores_gemma":[0.000008922905,0.0003197473,0.0004472058,0.0003601452,0.00008194563,0.00008868273,0.00003458427,0.001284279,0.00008906252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001116367,"about_ca_system_score_gemma":0.0006218258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001583632,"about_ca_topic_score_gemma":0.00002349962,"domain_scores_codex":[0.9982126,0.00004984165,0.0005190172,0.000495526,0.000363201,0.0003598018],"domain_scores_gemma":[0.9987545,0.00006339893,0.0004150703,0.0004437851,0.0002060689,0.000117148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003275907,0.0001145034,0.00001171987,0.004236996,0.0006307319,0.00003476143,0.000123372,0.000002177564,0.003668176,0.0001262406,0.0003518336,0.9906667],"study_design_scores_gemma":[0.000503581,0.0002050667,0.000004253367,0.01550168,0.00322606,0.0001074514,0.00005754159,0.00001610234,0.00216584,0.000008339046,0.9778382,0.0003658819],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001385606,0.992406,0.0005636324,0.0001557224,0.0006640035,0.0007845882,0.00007780922,0.0001249787,0.003837714],"genre_scores_gemma":[0.001856386,0.9951044,0.000215724,0.0006870124,0.0006711108,0.0001553811,0.0002369298,0.0001504781,0.000922541],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9903008,"threshold_uncertainty_score":0.9999254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069327639","doi":"10.1097/cad.0b013e328327994e","title":"Tranilast inhibits the growth and metastasis of mammary carcinoma","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Tranilast; Mammary carcinoma; Metastasis; Carcinoma; Cancer research; Internal medicine; Medicine; Oncology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.007622106464451463,"gpt":0.2393057148340062,"spread":0.2316836083695547,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006338078,0.0001201126,0.0001360652,0.00002450857,0.00006299741,0.00001618738,0.0001837452,0.00005318514,0.00000910731],"category_scores_gemma":[0.00001570218,0.00009050534,0.00007158448,0.00008081933,0.00009243147,0.000005659804,0.00004882997,0.00004991581,9.360889e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003417783,"about_ca_system_score_gemma":0.00007121525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003579406,"about_ca_topic_score_gemma":0.000005456247,"domain_scores_codex":[0.9993101,0.00003904347,0.000153438,0.0002294722,0.000111098,0.0001568945],"domain_scores_gemma":[0.99958,0.00001119982,0.00006885937,0.000240201,0.00004937084,0.0000503297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00004807693,0.00007403569,0.006597556,0.00004648769,0.00007375789,0.000001616554,0.0002515307,0.000009293376,0.9807436,0.0002440107,0.001146531,0.01076349],"study_design_scores_gemma":[0.0003640213,0.00008639076,0.04200055,0.00001576848,0.00004697474,0.000003201965,0.00006081081,0.000007480762,0.9554242,0.0000738446,0.001798007,0.0001187057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991401,0.007168019,0.0001229718,0.0005671591,0.00004114599,0.0001011933,0.00003509563,0.00000883825,0.0005545933],"genre_scores_gemma":[0.9983999,0.0005931871,0.0001586336,0.0006232136,0.0001041369,0.000008372291,0.00001865646,0.00001059178,0.00008331499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03540299,"threshold_uncertainty_score":0.3690701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999564272","doi":"10.1097/cad.0b013e3283287c20","title":"Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Prodrug; Pharmacokinetics; Pharmacology; Nicotinamide; Bolus (digestion); Therapeutic index; Chemistry; Mechanism of action; Medicine; In vitro; Drug; Internal medicine; Biochemistry; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.0145397641671311,"gpt":0.3048559351610278,"spread":0.2903161709938967,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002466294,0.0001765839,0.0001944931,0.00001925697,0.0001048131,0.00001505351,0.0004245464,0.0001697672,0.00003097441],"category_scores_gemma":[0.0000549619,0.0001249524,0.0001839404,0.0001532372,0.0001500608,0.000003759465,0.0001228262,0.0002085086,0.000006712698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002041717,"about_ca_system_score_gemma":0.0003392555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001838175,"about_ca_topic_score_gemma":0.00001731226,"domain_scores_codex":[0.9985008,0.00005989398,0.0003663263,0.0004190867,0.0003166456,0.0003372687],"domain_scores_gemma":[0.9992705,0.000009324667,0.00007144794,0.0004250845,0.0001181001,0.000105534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001068477,0.000230242,0.001164204,0.00003149959,0.00004500541,5.295729e-7,0.0001411337,0.000003687048,0.9608031,0.00003967912,0.001730332,0.03570372],"study_design_scores_gemma":[0.0006086248,0.00009119721,0.005498431,0.00005315959,0.00001422361,0.000001336807,0.00002634975,0.000006779468,0.9554971,0.00002976457,0.03800263,0.0001704149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957792,0.001445446,0.0001649239,0.001395156,0.000140785,0.0003491016,0.00001750202,0.00001103989,0.0006968849],"genre_scores_gemma":[0.9972348,0.0003541618,0.0004632589,0.0006491199,0.0001777771,0.00003196815,0.00003165363,0.00001696257,0.001040304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0362723,"threshold_uncertainty_score":0.5095413,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011397767","doi":"10.1097/00001813-200302000-00001","title":"Neovastat—a novel antiangiogenic drug for cancer therapy","year":2003,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Angiogenesis; Medicine; Drug; Clinical trial; Matrix metalloproteinase; Matrix metalloproteinase inhibitor; Multiple myeloma; Pharmacology; Cancer; Lung cancer; Apoptosis; Cancer research; Vascular endothelial growth factor; Oncology; Internal medicine; Biology; VEGF receptors","retraction":null,"screen_n_in":null,"score":{"opus":0.05688579399434322,"gpt":0.3725090845438742,"spread":0.3156232905495309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003979874,0.0009827787,0.001708216,0.0001585191,0.0002015823,0.00008924804,0.0009006624,0.0006531358,0.0002422293],"category_scores_gemma":[0.00002181403,0.0008761936,0.001603627,0.0003986518,0.0001756414,0.00001058827,0.0001266083,0.0003305085,0.00002942037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001799959,"about_ca_system_score_gemma":0.001749818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002569186,"about_ca_topic_score_gemma":0.00007155244,"domain_scores_codex":[0.9963428,0.000118858,0.0008010297,0.001440057,0.0003446763,0.0009525892],"domain_scores_gemma":[0.9977269,0.00006519389,0.0006828131,0.001066886,0.0002733433,0.0001848742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005130651,0.0001496281,0.00002665021,0.003348001,0.002066386,0.00000201005,0.00007552295,0.00003171125,0.006554243,0.00004083982,0.06121337,0.9264404],"study_design_scores_gemma":[0.001095734,0.00008005614,0.00000139622,0.00189954,0.0005777978,0.00000998147,0.00001383512,0.000003804412,0.01057704,0.000009402406,0.9846465,0.001084938],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004202664,0.9925359,0.0006657995,0.00008602409,0.002399916,0.001699967,0.001806019,0.00004523937,0.0003408123],"genre_scores_gemma":[0.00009883329,0.9852437,0.0006077985,0.0009194215,0.002297793,0.0020895,0.0007109685,0.0003473721,0.007684659],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9253554,"threshold_uncertainty_score":0.9993689,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2346252846","doi":"10.1097/cad.0000000000000366","title":"Pharmacokinetics of cabozantinib tablet and capsule formulations in healthy adults","year":2016,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Caprion (Canada); Celerion (Canada)","funders":"","keywords":"Bioequivalence; Cabozantinib; Cmax; Pharmacokinetics; Medicine; Dosing; Capsule; Confidence interval; Pharmacology; Medullary thyroid cancer; Urology; Cancer; Internal medicine; Thyroid cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.0155771152313709,"gpt":0.3132905311458384,"spread":0.2977134159144675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008432059,0.0001294554,0.0003078172,0.0001129553,0.00002932449,0.000003141003,0.00005033635,0.00005818716,0.0002567878],"category_scores_gemma":[0.00002454944,0.00009183151,0.0000365883,0.0001958308,0.00007600462,0.00009475103,0.00003616318,0.00007838366,0.00001272397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002138771,"about_ca_system_score_gemma":0.0003040969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001550038,"about_ca_topic_score_gemma":0.0001435207,"domain_scores_codex":[0.9989729,0.00001815397,0.0003122645,0.0002423249,0.0001768371,0.0002775151],"domain_scores_gemma":[0.99944,0.00005724587,0.0001110443,0.0002132824,0.0000742398,0.0001041969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002208259,0.0009494976,0.6577378,0.00117241,0.0003099471,0.00004560999,0.003924262,0.00002537372,0.1031,0.0006753492,0.004365149,0.2254863],"study_design_scores_gemma":[0.09236228,0.001081794,0.6645774,0.002886794,0.0003209171,0.00004204607,0.0003347705,0.001648432,0.2038264,0.0001490134,0.03219321,0.0005770433],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948489,0.001324879,0.00002789025,0.002132993,0.000110752,0.0004130512,0.00009559874,0.00002233833,0.001023568],"genre_scores_gemma":[0.9931449,0.005408482,0.0003159888,0.0003324528,0.00008656173,0.00003698295,0.00001391081,0.00002088564,0.0006398025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2249093,"threshold_uncertainty_score":0.374478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989545813","doi":"10.1097/01.cad.0000224442.78211.27","title":"Kinamycins A and C, bacterial metabolites that contain an unusual diazo group, as potential new anticancer agents: antiproliferative and cell cycle effects","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo; University of Manitoba","funders":"National Cancer Institute","keywords":"Topoisomerase; Chinese hamster ovary cell; Cell cycle; Diazo; Cell growth; Biochemistry; Biology; DNA synthesis; DNA gyrase; Cell; Mechanism of action; Chemistry; DNA; In vitro; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.005652982179236384,"gpt":0.2463329000675111,"spread":0.2406799178882747,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000127156,0.0003362442,0.0003666401,0.00005806386,0.0001723986,0.0001615933,0.0001408673,0.0001753567,0.00004336497],"category_scores_gemma":[0.000004472259,0.0003176348,0.00008553537,0.00008084698,0.0001356561,0.00003596241,0.0001309386,0.000108713,0.000002942968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002080588,"about_ca_system_score_gemma":0.0001226354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002401128,"about_ca_topic_score_gemma":0.0003273997,"domain_scores_codex":[0.9983867,0.00009662276,0.0002067072,0.0006725556,0.0001929045,0.0004445318],"domain_scores_gemma":[0.9993385,0.00001389882,0.0001271505,0.0002675418,0.00005460939,0.0001983124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003558579,0.0001252794,0.001876587,0.00004627545,0.0001085504,0.000008722285,0.0002165665,0.00001206347,0.9895836,0.0009105444,0.0002403995,0.00651557],"study_design_scores_gemma":[0.003660458,0.0005278359,0.01382,0.00002765589,0.0001754346,0.00001185283,0.0001476182,0.0001724336,0.9654715,0.000868332,0.01464768,0.0004692131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914132,0.005959313,0.001096295,0.0001609216,0.0005256853,0.0004358646,0.0000792827,0.00002418578,0.0003052124],"genre_scores_gemma":[0.9920465,0.004800171,0.000267952,0.0008283869,0.001186583,0.00004362268,0.0001647023,0.00005479444,0.0006072604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02411209,"threshold_uncertainty_score":0.9999276,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2332257070","doi":"10.1097/00001813-200303000-00002","title":"Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Depsipeptide; Cancer research; Carcinogenesis; DNA methylation; Histone deacetylase inhibitor; Breast carcinoma; Molecular biology; Chemistry; Epigenetics; Biology; Cancer; Histone deacetylase; Breast cancer; DNA; Histone; Gene expression; Gene; Biochemistry; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.008826567789554068,"gpt":0.2656592696472346,"spread":0.2568327018576806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001371132,0.0001665597,0.0002793976,0.0001250946,0.00004196817,0.000008490446,0.00004730706,0.0001186083,0.00001404357],"category_scores_gemma":[0.00005613991,0.0001638147,0.00003323517,0.0001029175,0.0001218786,0.00003584204,0.00006410259,0.0001291326,2.110482e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001916431,"about_ca_system_score_gemma":0.00003556969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006415425,"about_ca_topic_score_gemma":0.00009054425,"domain_scores_codex":[0.9990398,0.000100605,0.000286673,0.0003226423,0.0001181914,0.0001321054],"domain_scores_gemma":[0.9993206,0.00004311285,0.0003098424,0.0001872696,0.00009318583,0.00004595465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000223741,0.000290894,0.007510809,0.0002011715,0.00002605562,6.285489e-7,0.0001616685,0.0000223508,0.9898192,0.00001667765,0.00002233999,0.001704461],"study_design_scores_gemma":[0.001419015,0.0003009673,0.0291587,0.0002925204,0.00001997727,0.000008689413,0.0001685528,0.00002327177,0.968331,0.00001305027,0.0001321056,0.0001321524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991043,0.0001708981,0.0001480531,0.00002791413,0.0000716924,0.0003176602,0.00003853895,0.000003611045,0.0001173165],"genre_scores_gemma":[0.9993396,0.0001952708,0.0002834566,0.000008139928,0.00003525599,0.00003163728,0.00001099503,0.00001881701,0.00007676362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02164789,"threshold_uncertainty_score":0.6680171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007222488","doi":"10.1097/00001813-200206000-00010","title":"DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"DNA repair; Nucleotide excision repair; Cell culture; Mechanism of action; Drug resistance; Cancer research; DNA; Biology; Cancer; Molecular biology; Chemistry; Genetics; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.02489395193686691,"gpt":0.2900982614699908,"spread":0.2652043095331239,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005833992,0.0003047599,0.0002922701,0.00006827772,0.0002628035,0.00004541259,0.0007777588,0.00009577289,0.0000797247],"category_scores_gemma":[0.00005725471,0.0002164209,0.0002509887,0.0004705339,0.0003224086,0.00003114653,0.0001954572,0.0002644026,0.000003711679],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006563181,"about_ca_system_score_gemma":0.0001795181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005248084,"about_ca_topic_score_gemma":0.0022273,"domain_scores_codex":[0.9975736,0.000188632,0.0005047837,0.0006268438,0.0006613005,0.0004448446],"domain_scores_gemma":[0.9987286,0.00001945169,0.0003511477,0.0005850925,0.000263303,0.0000524245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006390842,0.0006393315,0.008047561,0.0003673161,0.0001491331,0.000007622757,0.00182385,0.0002500487,0.9666439,0.0009243556,0.01904881,0.0020342],"study_design_scores_gemma":[0.001087973,0.00004013994,0.006834855,0.0003928709,0.00004219034,0.000001885557,0.000222731,0.0004122503,0.9091898,0.0001664673,0.08118418,0.0004246435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99151,0.002332966,0.00003385786,0.001731276,0.0002407445,0.001313499,0.0001058808,0.00005756323,0.002674205],"genre_scores_gemma":[0.9896482,0.000159134,0.001659348,0.0009314459,0.0004529362,0.0007990765,0.000015978,0.00004546153,0.00628844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06213537,"threshold_uncertainty_score":0.8825388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073605475","doi":"10.1097/cad.0b013e32832ae55f","title":"The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Marine Sponges and Natural Products","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Apoptosis; Annexin; Caspase; Programmed cell death; Cancer cell; Cell biology; Biology; Cancer research; Chemistry; Cancer; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.005415570056929603,"gpt":0.239556438257086,"spread":0.2341408682001564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002552171,0.0002023956,0.0001804635,0.00003892497,0.0001177733,0.00004370263,0.0002970028,0.00007426812,0.00005198804],"category_scores_gemma":[0.00003632735,0.0001428555,0.00007842073,0.0001684657,0.00005183195,0.000006588505,0.0001772018,0.0001763629,0.0000132923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002493892,"about_ca_system_score_gemma":0.00006120873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006837255,"about_ca_topic_score_gemma":0.0004508602,"domain_scores_codex":[0.9987152,0.00004648844,0.0002347605,0.0004420881,0.000168574,0.0003929174],"domain_scores_gemma":[0.9993371,0.00001221631,0.00009196345,0.0004204854,0.0000727685,0.00006543788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001211988,0.0001172604,0.001842186,0.00002185979,0.0000347288,0.000005767426,0.00004669338,0.00002839514,0.9507459,0.00006718463,0.004421255,0.04254756],"study_design_scores_gemma":[0.0005591621,0.0001774687,0.006658269,0.00001402433,0.00001300071,0.000005560653,0.00004239855,0.00004697295,0.9665404,0.0001057845,0.02560288,0.0002341021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921989,0.001676068,0.00000182045,0.003941975,0.0002747294,0.0003162809,0.00001472308,0.00001733957,0.001558205],"genre_scores_gemma":[0.9907345,0.003372015,0.00007870523,0.0007757001,0.0004074554,0.00002464871,0.00004202901,0.00001892664,0.004546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04231346,"threshold_uncertainty_score":0.582548,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2794034349","doi":"10.1097/cad.0000000000000589","title":"Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; QT interval; Placebo; Breast cancer; Dosing; Internal medicine; Anesthesia; Cardiology; Metastatic breast cancer; Cancer; Aromatase","retraction":null,"screen_n_in":null,"score":{"opus":0.01114831229344271,"gpt":0.2969571145477851,"spread":0.2858088022543424,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004163493,0.0004784071,0.00077957,0.0001176459,0.0001968659,0.00004407982,0.0003576662,0.0001347106,0.0009499173],"category_scores_gemma":[0.00009548712,0.0002773959,0.0001626324,0.0004871041,0.0007804992,0.0002420727,0.0001030383,0.0006472432,0.0002588575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003909546,"about_ca_system_score_gemma":0.0002855466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003795598,"about_ca_topic_score_gemma":0.0002045494,"domain_scores_codex":[0.9970579,0.0001662257,0.0006053559,0.0007777718,0.0006781246,0.0007146837],"domain_scores_gemma":[0.9978276,0.0003535242,0.0003338466,0.0008271213,0.0004804268,0.0001774327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02131905,0.0005854408,0.7118337,0.0001362988,0.0003683493,0.00001321031,0.001343172,0.00003764535,0.001416628,0.00005182887,0.001014401,0.2618803],"study_design_scores_gemma":[0.01759339,0.005070401,0.9452544,0.003154109,0.0001587136,0.00000770648,0.0001619529,0.0001027978,0.004946396,0.00005899691,0.02286519,0.0006259829],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897168,0.0002497437,0.0000301445,0.00657366,0.0008265534,0.001286019,0.0001219217,0.0001158078,0.001079373],"genre_scores_gemma":[0.9916697,0.0002040558,0.0002323929,0.00589342,0.0008572874,0.00037705,0.00001868002,0.0001168536,0.0006306297],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2612543,"threshold_uncertainty_score":0.9999678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326953798","doi":"10.1097/00001813-200304000-00005","title":"Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Cytotoxic T cell; Etoposide; Caveolin 1; Cancer cell; Drug; Doxorubicin; Drug resistance; Multiple drug resistance; Cancer; Biology; Cancer research; Cell culture; Pharmacology; Chemistry; Cell biology; In vitro; Chemotherapy; Biochemistry; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.00914706126737542,"gpt":0.263314680700401,"spread":0.2541676194330256,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001477156,0.0001892189,0.0002293045,0.00005679491,0.00004983177,0.00001128819,0.0001167793,0.000143539,0.0001122416],"category_scores_gemma":[0.00001421665,0.0001875979,0.00008253548,0.0001672667,0.00006738732,0.00001008892,0.00004746587,0.00009135153,0.000006419343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003598434,"about_ca_system_score_gemma":0.0001424481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005557236,"about_ca_topic_score_gemma":0.0001799615,"domain_scores_codex":[0.9987754,0.00008029335,0.0002865358,0.0004007664,0.0001835456,0.000273437],"domain_scores_gemma":[0.9994057,0.000009414129,0.0001692052,0.0002379313,0.0001143056,0.00006344451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00004601439,0.00008045396,0.002342757,0.00006032174,0.0000232833,9.282285e-7,0.0003650607,0.0003059438,0.9897346,0.00001176962,0.00637053,0.0006583757],"study_design_scores_gemma":[0.0008299566,0.00002209866,0.0009162554,0.00008514146,0.00001607739,9.169549e-7,0.0003147175,0.00004637443,0.9868864,0.00002694276,0.01063536,0.0002197638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959532,0.002414438,0.0002199612,0.00004541919,0.0002998497,0.0002125437,0.00009600985,0.00000731968,0.0007512429],"genre_scores_gemma":[0.9928833,0.002967722,0.00004273296,0.0001953441,0.00009020559,0.00004618894,0.0001058183,0.00002882487,0.00363992],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004264827,"threshold_uncertainty_score":0.765002,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2329169495","doi":"10.1097/00001813-200203000-00002","title":"The role of DNA repair in nitrogen mustard drug resistance","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"","keywords":"RAD51; Nitrogen mustard; DNA repair; DNA damage; DNA; Homologous recombination; Cancer research; Biology; Homologous chromosome; Chemistry; Genetics; Gene; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01127086749038701,"gpt":0.2701371615645701,"spread":0.258866294074183,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004482142,0.0004261419,0.0009666682,0.0000811361,0.00008792092,0.00001669866,0.0007172043,0.0003359097,0.00003187174],"category_scores_gemma":[0.00005062671,0.0003240897,0.0007440737,0.0002880876,0.0001354837,0.000004353668,0.0002471507,0.0002715162,0.00002334049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007615823,"about_ca_system_score_gemma":0.0002758407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006633961,"about_ca_topic_score_gemma":0.0003265899,"domain_scores_codex":[0.9975954,0.0002476042,0.0007285764,0.0006856615,0.0002764043,0.0004663487],"domain_scores_gemma":[0.9981532,0.00005028187,0.0004907727,0.001146344,0.00009049616,0.00006889165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006672862,0.0002259164,0.0001164062,0.007830663,0.001057478,0.0000191189,0.0002972659,0.00000281242,0.005327074,0.000758922,0.02790705,0.9563906],"study_design_scores_gemma":[0.0001689862,0.00001726013,6.728591e-7,0.001754756,0.0001588783,0.000002528108,0.0000745674,0.00000285823,0.01930784,0.0002031443,0.9779732,0.0003352769],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001963781,0.9945019,0.000001494073,0.00003602017,0.0002179877,0.0006242482,0.000150123,0.00003107504,0.002473296],"genre_scores_gemma":[0.0007014616,0.990142,0.0001767119,0.00004898149,0.0002286845,0.0002569905,0.00007627726,0.00008942585,0.008279475],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9560553,"threshold_uncertainty_score":0.9999211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006614996","doi":"10.1097/00001813-200010000-00007","title":"Irinotecan-associated pulmonary toxicity","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Irinotecan; Interstitial lung disease; Pulmonary toxicity; Pulmonary function testing; Adverse effect; Disease; Lung cancer; Internal medicine; Complication; Pneumonitis; Intensive care medicine; Clinical trial; Colorectal cancer; Cancer; Lung; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.009231034895599156,"gpt":0.2549069427323571,"spread":0.2456759078367579,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001088677,0.0001782559,0.0001691796,0.00002445976,0.0001134556,0.0000253237,0.0002147073,0.0001598761,0.001012017],"category_scores_gemma":[0.000003621283,0.0001804921,0.0001227762,0.0001164098,0.00005307119,0.000004625601,0.00004773349,0.0001009406,0.00005747999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003809015,"about_ca_system_score_gemma":0.00009145939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002420561,"about_ca_topic_score_gemma":0.00009217406,"domain_scores_codex":[0.9989106,0.00003327121,0.0001686858,0.0003815187,0.0001544344,0.0003515095],"domain_scores_gemma":[0.9994784,0.000004322989,0.00005616451,0.000322911,0.00004993385,0.00008824174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007472512,0.0001951124,0.0004522588,0.000007936687,0.0001099914,0.000003578012,0.00006793363,0.00008116479,0.8541201,0.00007272034,0.001738592,0.1430759],"study_design_scores_gemma":[0.0005354437,0.0001370108,0.001534542,0.00001939716,0.00002931399,0.000004126681,0.00003406443,0.0001312067,0.7055815,0.0001707578,0.2915068,0.0003158382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874579,0.001384499,0.00006818627,0.0003815483,0.000235581,0.000144085,0.00007858715,0.00003518202,0.01021447],"genre_scores_gemma":[0.9808085,0.004305429,0.00003977399,0.002087351,0.0003296965,0.00003970487,0.00008993656,0.0000354095,0.01226419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2897682,"threshold_uncertainty_score":0.9999012,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2333659151","doi":"10.1097/cad.0b013e328334992c","title":"Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer","year":2010,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Tranilast; Cancer research; Cell growth; Apoptosis; Cyclin D1; Cell cycle; Chemistry; Cyclin D; Medicine; Pharmacology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.004213468023178503,"gpt":0.2321104284673323,"spread":0.2278969604441538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006502034,0.0001358681,0.000113085,0.00004567979,0.00006217458,0.00004323778,0.00005441833,0.0001051902,0.00002768499],"category_scores_gemma":[0.000008712599,0.0001296511,0.00002080014,0.0000712609,0.00007038816,0.00001486044,0.00003579781,0.00009493534,9.969524e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007202493,"about_ca_system_score_gemma":0.00008315989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000360932,"about_ca_topic_score_gemma":0.002168912,"domain_scores_codex":[0.9992567,0.000021916,0.0001536831,0.0003224164,0.0000862754,0.0001590206],"domain_scores_gemma":[0.9996876,0.000005735531,0.00006010435,0.0001216584,0.00005965295,0.00006530109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003949004,0.00009117514,0.1123228,0.00007524488,0.00001000768,1.711474e-7,0.0003015519,0.00001315931,0.8827217,0.00000353364,0.0001143263,0.004306879],"study_design_scores_gemma":[0.0006225908,0.00003304645,0.08300978,0.00003755387,0.00001675264,0.000002629934,0.00004068141,0.0001496204,0.9151571,0.000008518564,0.0007605348,0.0001611888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981904,0.0008340821,0.00001553153,0.0005157779,0.00008391845,0.0002398406,0.00006403092,0.00001210597,0.000044327],"genre_scores_gemma":[0.998569,0.0006165256,0.0001200474,0.0001376722,0.0002402867,0.0001008513,0.00005517929,0.00001922114,0.0001412259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03243542,"threshold_uncertainty_score":0.5287017,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093477091","doi":"10.1097/00001813-200402000-00010","title":"Evaluation of antineoplastic action of 5-aza-2???-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Docetaxel; Cancer research; Carcinoma; Oncology; Breast carcinoma; Clonogenic assay; Medicine; Internal medicine; Biology; Cancer; Cell culture; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03415982134665608,"gpt":0.3221899053774003,"spread":0.2880300840307442,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004255059,0.0002383656,0.0004548233,0.0002343981,0.00007513649,0.00001204301,0.00005237099,0.0001197593,0.00004076422],"category_scores_gemma":[0.00003556671,0.0002225224,0.00007711958,0.0002642336,0.0001493498,0.0001182352,0.00004205895,0.0001950278,0.00000217008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001655144,"about_ca_system_score_gemma":0.00034767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008132314,"about_ca_topic_score_gemma":0.00008305652,"domain_scores_codex":[0.9981906,0.00006464623,0.0004284251,0.0004121184,0.0006668319,0.0002373761],"domain_scores_gemma":[0.9987385,0.00002955121,0.000339616,0.0002789524,0.0005071252,0.0001062675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003450537,0.0003184579,0.01830501,0.001018752,0.0001517581,0.00000877927,0.001018788,0.001317789,0.966745,0.00005166954,0.0000781868,0.0106408],"study_design_scores_gemma":[0.009665232,0.000529433,0.1551139,0.0008522721,0.001139904,0.00007441048,0.0001639289,0.002566007,0.8295361,0.00009000336,0.00003790488,0.0002307988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995412,0.002696365,0.00007832963,0.0003085157,0.0001691701,0.0008312607,0.00008183611,0.00002963874,0.0003929037],"genre_scores_gemma":[0.9987933,0.0007109453,0.0001078473,0.00005295116,0.0001372643,0.00003398946,0.00004089722,0.00004173224,0.00008107525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1372088,"threshold_uncertainty_score":0.90742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2333517888","doi":"10.1097/00001813-200301000-00004","title":"In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sulfasalazine; In vitro; Inhibitory postsynaptic potential; Lymphoma; Cancer research; Pharmacology; Chemistry; Medicine; Immunology; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04701858184242599,"gpt":0.3052550081109162,"spread":0.2582364262684902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004712766,0.0001257435,0.0002502213,0.00002530676,0.00005396318,0.000006535292,0.0001109245,0.00007814656,0.0003592892],"category_scores_gemma":[0.0004361456,0.00007312679,0.00007947795,0.0001308272,0.0001221879,0.00005274361,0.00002644741,0.00007699326,0.00001419535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009499241,"about_ca_system_score_gemma":0.00004635222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006853328,"about_ca_topic_score_gemma":0.000007730823,"domain_scores_codex":[0.9991074,0.0001020848,0.0002023818,0.0002162743,0.0002098442,0.0001620761],"domain_scores_gemma":[0.9990939,0.0004801741,0.0001422599,0.0001903256,0.00007430201,0.00001897632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007422797,0.0002102674,0.002089498,0.00004678413,0.00004725346,9.581798e-7,0.0002356665,0.000004804809,0.9900983,0.0006123608,0.0005393869,0.006040481],"study_design_scores_gemma":[0.0003795928,0.00001271336,0.003091109,0.00005649854,0.00001334488,2.857619e-7,0.0003865045,0.00002755681,0.9946653,0.0004488463,0.0008212241,0.00009706359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991242,0.0006018227,6.190023e-7,0.001005052,0.0001397593,0.00006106366,0.00001184266,0.00001453481,0.006923302],"genre_scores_gemma":[0.9985268,0.0006387436,0.00001114746,0.0002838904,0.000100985,0.00004573939,0.00000116925,0.000008098769,0.0003834627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00728476,"threshold_uncertainty_score":0.3933965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975493627","doi":"10.1097/cad.0b013e328333d679","title":"Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sunitinib; Sorafenib; Platelet-derived growth factor receptor; Cancer research; Medicine; Tyrosine kinase; Vascular endothelial growth factor; Pathophysiology; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Recall; Cancer; Pharmacology; Internal medicine; Oncology; Receptor; VEGF receptors; Growth factor; Psychology; Hepatocellular carcinoma","retraction":null,"screen_n_in":null,"score":{"opus":0.01159465996908823,"gpt":0.2769148304306642,"spread":0.265320170461576,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001907446,0.0002948986,0.0005007819,0.0001508455,0.0001330969,0.0000468041,0.00008784081,0.0002570641,0.0002864102],"category_scores_gemma":[0.00008177778,0.0002860056,0.0001020876,0.0004068446,0.0001054426,0.0002451777,0.00001752515,0.0003524599,0.00002856214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001447042,"about_ca_system_score_gemma":0.0001031042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000445627,"about_ca_topic_score_gemma":0.00002025951,"domain_scores_codex":[0.9983213,0.00007876694,0.000472275,0.0004278134,0.0003019039,0.0003979579],"domain_scores_gemma":[0.9990555,0.00006691415,0.0002073297,0.0003102652,0.0001256728,0.0002342838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002307405,0.0008499565,0.006065916,0.0001227246,0.0001852476,0.00004429339,0.002660159,0.000008543545,0.5816472,0.00002385535,0.07463315,0.3335282],"study_design_scores_gemma":[0.01310431,0.0002351814,0.03682808,0.0003938272,0.0001754824,0.000032008,0.0001478309,0.001214072,0.9024535,0.00005498548,0.0448524,0.0005082577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9772438,0.01270762,0.0001571725,0.008304073,0.0001989291,0.0006653641,0.0001064475,0.0002184407,0.0003981046],"genre_scores_gemma":[0.9855953,0.006688382,0.0009984103,0.004969948,0.0002818085,0.00002227706,0.0002400467,0.00004827788,0.001155495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3330199,"threshold_uncertainty_score":0.9999592,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076804008","doi":"10.1097/cad.0b013e328011a532","title":"Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Neutropenia; Febrile neutropenia; Chemotherapy; Absolute neutrophil count; Internal medicine; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.007428577568633091,"gpt":0.2857925743261888,"spread":0.2783639967575557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001531718,0.000175666,0.0004025873,0.0001435842,0.00006768525,0.000009612856,0.00007007945,0.00007136731,0.000333698],"category_scores_gemma":[0.000008435329,0.0001399957,0.00005041289,0.0004151001,0.0001582118,0.00009531819,0.00002389726,0.0002299451,0.000002011647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001095848,"about_ca_system_score_gemma":0.0001621507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002754724,"about_ca_topic_score_gemma":0.000607082,"domain_scores_codex":[0.9988747,0.00001739009,0.000285342,0.0003156358,0.0002034983,0.0003034055],"domain_scores_gemma":[0.9994009,0.00006019378,0.0001392707,0.0002105433,0.00008607508,0.0001030431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008161952,0.0001375087,0.9296483,0.00004455011,0.0002026476,0.000003767557,0.0009527665,0.00006901372,0.009451432,0.0000360542,0.0001824709,0.05845525],"study_design_scores_gemma":[0.005667578,0.0001295666,0.94234,0.0004253654,0.00009993147,0.00002543553,0.000122349,0.000009424701,0.04945658,0.000005205334,0.001558082,0.0001605453],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949459,0.001178075,0.0001080424,0.0008047566,0.00008999037,0.0005339673,0.00002551949,0.00003232496,0.00228137],"genre_scores_gemma":[0.9938991,0.004751368,0.0001552721,0.0004470283,0.0002059557,0.00002817067,0.000008958506,0.00003449352,0.0004696418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0582947,"threshold_uncertainty_score":0.5708857,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2327085958","doi":"10.1097/00001813-200008000-00012","title":"Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Letrozole; Anastrozole; Megestrol acetate; Medicine; Megestrol; Aromatase; Randomized controlled trial; Oncology; Hormonal therapy; Internal medicine; Quality-adjusted life year; Breast cancer; Quality of life (healthcare); Clinical trial; Aromatase inhibitor; Cancer; Gynecology; Cost effectiveness","retraction":null,"screen_n_in":null,"score":{"opus":0.03360241873040829,"gpt":0.3932203057889453,"spread":0.359617887058537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001840646,0.0002741528,0.001304019,0.0004086943,0.00003660208,0.000005464842,0.000146318,0.00007493774,0.007602059],"category_scores_gemma":[0.000002749168,0.0002409319,0.0002749594,0.00151322,0.0001371939,0.0001092755,0.00002576318,0.0002061861,0.000007334275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001898692,"about_ca_system_score_gemma":0.0002507999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006021175,"about_ca_topic_score_gemma":0.005048953,"domain_scores_codex":[0.9980337,0.00008472052,0.0007377574,0.0004495135,0.0003153693,0.0003789242],"domain_scores_gemma":[0.9990023,0.00007682818,0.0002520956,0.0003452887,0.0001359126,0.0001875982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006134512,0.001667884,0.6513211,0.0000818834,0.00214753,0.000009616671,0.002552934,0.005914977,0.05990072,0.000003063691,0.001444086,0.2688218],"study_design_scores_gemma":[0.01341008,0.0006168151,0.8027509,0.000144172,0.001557724,0.000003156126,0.0002548352,0.003327854,0.1727509,0.000008735839,0.004887553,0.0002872947],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921433,0.00306802,0.000003652152,0.001344683,0.000121349,0.0008692162,0.002152175,0.00002535829,0.0002722779],"genre_scores_gemma":[0.9958246,0.002666527,0.00008601433,0.000534622,0.0001025306,0.0002346438,0.0002115491,0.00002202717,0.0003175173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2685345,"threshold_uncertainty_score":0.9933051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987526635","doi":"10.1097/cad.0b013e3282eea257","title":"Apoptotic pathway induced by noscapine in human myelogenous leukemic cells","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Toronto; Iran University of Medical Sciences","keywords":"Noscapine; Apoptosis; DNA fragmentation; Phosphatidylserine; Poly ADP ribose polymerase; Chemistry; K562 cells; Caspase; Cell biology; Molecular biology; Programmed cell death; Cancer research; Biology; Biochemistry; Alkaloid; DNA; Polymerase","retraction":null,"screen_n_in":null,"score":{"opus":0.008083415128999077,"gpt":0.2518857493428008,"spread":0.2438023342138018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002561788,0.0001785021,0.0001754183,0.00007193608,0.00008758873,0.00001597409,0.0001554891,0.0002234674,0.00005035174],"category_scores_gemma":[0.000003528441,0.0001741572,0.00007143703,0.0001359493,0.00003548248,0.000004776398,0.00006177476,0.0001150112,0.00001215201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005845884,"about_ca_system_score_gemma":0.0000627418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004342006,"about_ca_topic_score_gemma":0.0001865307,"domain_scores_codex":[0.9988068,0.00002509231,0.0002745584,0.0003801029,0.0001372218,0.000376186],"domain_scores_gemma":[0.9995128,0.000005654158,0.00009604904,0.0002679215,0.00004225704,0.00007534905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001859579,0.00007362061,0.000263111,0.00001659341,0.00001692034,0.000002486215,0.0001288013,0.00004803334,0.9893147,0.00006115472,0.0003865951,0.009669426],"study_design_scores_gemma":[0.0007609908,0.000114971,0.002320488,0.00001885726,0.000008297582,0.000001765371,0.00008989685,0.00003076386,0.9873284,0.00004440628,0.009042387,0.0002387426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969939,0.001016686,0.0005832749,0.00004409675,0.0002788774,0.0002120149,0.00001460699,0.00001561423,0.0008409174],"genre_scores_gemma":[0.9968134,0.0005970877,0.0000896284,0.0002629136,0.0002486903,0.00001214563,0.0001681068,0.00003222693,0.001775789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009430683,"threshold_uncertainty_score":0.7101926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805530155","doi":"10.1097/cad.0000000000000661","title":"A case of severe Pembrolizumab-induced neutropenia","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Neutropenia; Immunosuppression; Adverse effect; Internal medicine; Immunology; Gastroenterology; Cancer; Chemotherapy; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02603540285744438,"gpt":0.3146937041468664,"spread":0.288658301289422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001324436,0.0001688654,0.0003634896,0.00009710764,0.00009636379,0.0000132577,0.0001077039,0.00009504292,0.001245358],"category_scores_gemma":[0.000009155416,0.0001392471,0.0001575586,0.0003321078,0.0001946844,0.00009721726,0.00004028894,0.0001260946,0.00005440916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008323551,"about_ca_system_score_gemma":0.0002487588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003133872,"about_ca_topic_score_gemma":0.0002198208,"domain_scores_codex":[0.9989239,0.00003066702,0.0003026025,0.0002778912,0.0001840613,0.000280872],"domain_scores_gemma":[0.9991316,0.00002418951,0.0001391016,0.000418115,0.0001942961,0.00009271134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006545073,0.0003548443,0.01073893,0.0003488463,0.0008049406,0.0007203136,0.004519548,8.336052e-7,0.8261752,0.0002151558,0.01621851,0.1333578],"study_design_scores_gemma":[0.02267234,0.002185734,0.04045101,0.0007174664,0.0005316422,0.00604406,0.001649428,0.0001303539,0.8559225,0.00007790919,0.06879282,0.0008247411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861304,0.000556122,0.000004041588,0.0007471008,0.0004360714,0.0003076,0.00002797679,0.00004831818,0.01174235],"genre_scores_gemma":[0.9957727,0.0003357018,0.00009938786,0.001196888,0.0004872426,0.00002156943,0.000005599449,0.00003178259,0.002049184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1325331,"threshold_uncertainty_score":0.9996676,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078410820","doi":"10.1097/cad.0000000000000043","title":"Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells","year":2013,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"ABCC1; Abcg2; Cytotoxicity; Efflux; Multiple drug resistance; SKBR3; Cytotoxic T cell; Viability assay; Pharmacology; ATP-binding cassette transporter; Biology; Cancer research; Cancer cell; Transporter; Cancer; Drug resistance; Apoptosis; In vitro; Biochemistry; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.008272261964458742,"gpt":0.2499829644748366,"spread":0.2417107025103779,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001185768,0.0004142524,0.0006890546,0.0001733403,0.0002277094,0.0001046136,0.0001900408,0.0001793112,0.002019125],"category_scores_gemma":[0.00000366679,0.0003382672,0.0001500488,0.0003449095,0.0001273987,0.0003081963,0.00005998691,0.0003095836,0.0002236476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001434981,"about_ca_system_score_gemma":0.000164325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001979491,"about_ca_topic_score_gemma":0.0002163754,"domain_scores_codex":[0.9976537,0.00002534266,0.0004111019,0.0007003579,0.0004839019,0.0007255844],"domain_scores_gemma":[0.9985982,0.00002869043,0.0001668429,0.0004772014,0.0002005293,0.0005284885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0001932559,0.0002398614,0.06032809,0.0006808237,0.0002138296,0.0000595231,0.001971919,0.00005855396,0.9058975,0.00009511544,0.01200178,0.01825976],"study_design_scores_gemma":[0.004040991,0.00009668406,0.5111665,0.003247589,0.0003682606,0.0000436323,0.0022524,0.000238963,0.4588948,0.0001541373,0.01840317,0.001092932],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884651,0.001436335,0.0002516417,0.00590305,0.0006381696,0.001007519,0.000260077,0.0001491869,0.001888903],"genre_scores_gemma":[0.9867324,0.001883802,0.0007947274,0.003268996,0.0006058301,0.0002504044,0.000014068,0.00009243358,0.006357393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4508384,"threshold_uncertainty_score":0.999907,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2036467698","doi":"10.1097/cad.0b013e32835006f5","title":"A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Protopanaxadiol; Pharmacokinetics; Pharmacology; Oral administration; Cmax; Prostate cancer; Aglycone; Chemistry; Ginsenoside; Cancer; Medicine; Internal medicine; Stereochemistry; Ginseng; Glycoside","retraction":null,"screen_n_in":null,"score":{"opus":0.02488769082289438,"gpt":0.2892342967145998,"spread":0.2643466058917054,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001762935,0.0001763847,0.0002400125,0.00002304316,0.00009328215,0.000006984441,0.0001445397,0.0001254344,0.000002392236],"category_scores_gemma":[0.00001711517,0.0001157683,0.0001345502,0.0001504584,0.0001472384,0.00001505575,0.00009656647,0.0001091579,6.500475e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002686686,"about_ca_system_score_gemma":0.0001108565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003295905,"about_ca_topic_score_gemma":0.00004769414,"domain_scores_codex":[0.999061,0.00005825164,0.0002095667,0.0002455817,0.0001398834,0.0002857376],"domain_scores_gemma":[0.9992037,0.00001979279,0.0002728442,0.0003159088,0.0001304072,0.00005734917],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001213958,0.0002104668,0.004512234,0.00003651685,0.00007840029,3.229354e-8,0.0002853344,0.001442456,0.9850585,0.0001671817,0.00004306906,0.008044417],"study_design_scores_gemma":[0.0007161818,0.00007761607,0.04735045,0.00003771955,0.00004488492,7.35933e-7,0.00003670055,0.004952507,0.9461346,0.00002887294,0.0004523754,0.0001673893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995803,0.0006473704,0.001507649,0.0002811711,0.00004698433,0.001234883,0.0003122188,0.00001014826,0.000156564],"genre_scores_gemma":[0.9983006,0.0005565381,0.0001971676,0.0002930982,0.00009712502,0.0003701149,0.00002821973,0.00001896272,0.0001381561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04283821,"threshold_uncertainty_score":0.4720896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041352031","doi":"10.1097/00001813-200501000-00014","title":"The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Daunorubicin; Doxorubicin; Anthracycline; Pharmacology; Chemistry; Reactive oxygen species; Biochemistry; Biology; Leukemia; Medicine; Chemotherapy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01420703015193624,"gpt":0.2608693665313333,"spread":0.2466623363793971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003111391,0.0002173043,0.000371122,0.00005582926,0.0003450984,0.00005021872,0.0001327808,0.0001052987,0.00001220487],"category_scores_gemma":[0.00007209589,0.0001296964,0.0001243276,0.0003276343,0.0004289198,0.0004167827,0.00004782057,0.0002684313,0.000008154895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001125455,"about_ca_system_score_gemma":0.0001231806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007281744,"about_ca_topic_score_gemma":0.00007045106,"domain_scores_codex":[0.9985794,0.00005605799,0.0004205082,0.0002626588,0.0004016607,0.0002796876],"domain_scores_gemma":[0.9988803,0.0002134216,0.0003164593,0.0003279758,0.0002089747,0.00005282522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000206022,0.00009957414,0.0005958423,0.0001578032,0.00006046742,0.00000326701,0.008576943,0.00002698187,0.9873328,0.001190382,0.0005091526,0.001240764],"study_design_scores_gemma":[0.002544147,0.0001076657,0.009583054,0.0002286633,0.0001049407,0.00001693061,0.005602867,0.00003154598,0.9782026,0.0005782199,0.002846086,0.0001532096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832371,0.001221327,0.0001875523,0.01064642,0.0001731573,0.0007126006,0.00004902733,0.00004123743,0.0037315],"genre_scores_gemma":[0.9866558,0.01137596,0.0001026238,0.001169507,0.0003231116,0.00003150704,0.00004599005,0.000027013,0.0002685349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01015464,"threshold_uncertainty_score":0.5288868,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985842761","doi":"10.1097/cad.0000000000000145","title":"Integrins","year":2014,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"China Scholarship Council; McGill University Health Centre","keywords":"Integrin; Extracellular matrix; Cell biology; Cell adhesion; Signal transduction; Cell surface receptor; Intracellular; Motility; Cell adhesion molecule; Receptor; Cancer research; Cell; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.0640475224849201,"gpt":0.4258113649242002,"spread":0.3617638424392801,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003320248,0.0004694551,0.002464464,0.0003726553,0.00006388372,0.00004107699,0.0004094865,0.0003969076,0.002429541],"category_scores_gemma":[0.00009988984,0.0003347741,0.0008598777,0.0005272599,0.0001304956,0.00003222466,0.0002448579,0.001176526,0.003579583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002980034,"about_ca_system_score_gemma":0.0009464459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001439881,"about_ca_topic_score_gemma":0.000007371448,"domain_scores_codex":[0.9973676,0.000154771,0.0005973453,0.0006651124,0.0006710015,0.0005442274],"domain_scores_gemma":[0.9982182,0.0001688059,0.000218764,0.0009352823,0.0001511176,0.0003077818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005348586,0.0000602264,0.00001659005,0.02546523,0.0001915456,0.00003581275,0.0000244316,4.088427e-8,0.00001003943,0.00007332465,0.02117512,0.9529423],"study_design_scores_gemma":[0.0003378433,0.00006257359,0.00001041832,0.01728814,0.000648306,0.00003650424,0.00001041654,0.000006195977,0.00006088569,0.000004846088,0.9812302,0.0003036622],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002785216,0.9791086,0.00002873175,0.0002119876,0.0003294883,0.0009415386,0.00002768913,0.00009231751,0.01923175],"genre_scores_gemma":[0.00001961996,0.9691694,0.0001020769,0.0003568225,0.000826268,0.0002084748,0.0001427598,0.0001430578,0.02903146],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9600551,"threshold_uncertainty_score":0.9999104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062392807","doi":"10.1097/cad.0b013e32835a56bc","title":"Peg-filgrastim and cabazitaxel in prostate cancer patients","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McGill University","keywords":"Cabazitaxel; Febrile neutropenia; Medicine; Neutropenia; Filgrastim; Internal medicine; Prostate cancer; Docetaxel; Surgery; Oncology; Cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01156542653961017,"gpt":0.2956856069601163,"spread":0.2841201804205061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008967007,0.0001705939,0.0002831759,0.0001173127,0.00008647053,0.00001860268,0.00004666225,0.00005215274,0.0003710354],"category_scores_gemma":[0.00001019665,0.0001470265,0.00004852218,0.0002812996,0.00007977804,0.000263952,0.00004653424,0.000216241,0.0000411503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001595865,"about_ca_system_score_gemma":0.0001148137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003055501,"about_ca_topic_score_gemma":0.0003640077,"domain_scores_codex":[0.9988584,0.00002391099,0.0002167695,0.0002469384,0.0002004412,0.0004535697],"domain_scores_gemma":[0.9994679,0.00001935913,0.00007195382,0.0001592361,0.00008745339,0.000194073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006445954,0.0002418509,0.9807564,0.00008799254,0.00003877592,0.000002127136,0.001369164,0.000004786204,0.001554973,0.00005464288,0.003362617,0.01246218],"study_design_scores_gemma":[0.002669593,0.00008393075,0.9533401,0.0001861432,0.0000902205,0.000005305123,0.000188746,0.00001311054,0.00502586,0.00001587895,0.03817162,0.0002095171],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991612,0.002599025,0.000001804386,0.0009081812,0.0006660748,0.0004840702,0.00006101703,0.00004157145,0.003626245],"genre_scores_gemma":[0.9930688,0.002923164,0.00003097717,0.0009022216,0.0003083135,0.0002871512,0.00001733665,0.00003184086,0.002430174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.034809,"threshold_uncertainty_score":0.5995566,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062686953","doi":"10.1097/00001813-200504000-00009","title":"In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Doxorubicin; Toxicity; Mitomycin C; Microsphere; In vivo; Therapeutic index; Pharmacology; Chemotherapy; Medicine; Dextran; Chemistry; Surgery; Drug; Internal medicine; Biology; Chromatography","retraction":null,"screen_n_in":null,"score":{"opus":0.01139503563033102,"gpt":0.2569178602094529,"spread":0.2455228245791219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002006087,0.0001443722,0.0002459397,0.00007074094,0.00009104149,0.00004912885,0.00009194355,0.00005246495,0.0001172647],"category_scores_gemma":[0.00001541877,0.0001326521,0.00001498695,0.0002615764,0.0001075582,0.0006811494,0.00005524707,0.00007191705,0.000004327066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008437689,"about_ca_system_score_gemma":0.00008944105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006179285,"about_ca_topic_score_gemma":0.0004998869,"domain_scores_codex":[0.9989247,0.00005418584,0.0003008631,0.0002881713,0.0001842082,0.0002479144],"domain_scores_gemma":[0.999446,0.00007336937,0.0001538223,0.0001374067,0.0001239954,0.00006537765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001136308,0.0001593921,0.004392481,0.00004672907,0.000006079923,0.000002413072,0.000810214,0.002662826,0.9911673,0.0002203103,0.00004534667,0.0003732665],"study_design_scores_gemma":[0.002534137,0.00007370304,0.006617249,0.0001371228,0.00002708682,0.000005179516,0.00008866511,0.0145167,0.9757644,0.00003719815,0.00003140892,0.0001671607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984618,0.0006315315,0.00008431559,0.0003301244,0.00005307316,0.0003335411,0.00003750822,0.00002337902,0.00004471838],"genre_scores_gemma":[0.9976313,0.00009513178,0.002024044,0.0001450024,0.00003451017,0.000008112924,0.000001493382,0.00001497302,0.00004543961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01540292,"threshold_uncertainty_score":0.5409397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977609704","doi":"10.1097/cad.0b013e32832f4aa8","title":"Methotrexate-induced apoptosis is enhanced by altered expression of methylenetetrahydrofolate reductase","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Methylenetetrahydrofolate reductase; TUNEL assay; Apoptosis; Methotrexate; Terminal deoxynucleotidyl transferase; Hyperhomocysteinemia; Methyltransferase; Pharmacology; Chemistry; Homocysteine; Molecular biology; Biology; Endocrinology; Internal medicine; Cancer research; Methylation; Biochemistry; Medicine; DNA; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.02680360271157377,"gpt":0.35476926397037,"spread":0.3279656612587962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000362852,0.0003006782,0.0007140723,0.000250865,0.00009780691,0.00002243227,0.000255943,0.0002078096,0.0007418352],"category_scores_gemma":[0.0000547326,0.0002464515,0.0002354918,0.0006343382,0.00007576454,0.0002132155,0.00005693193,0.0003860309,0.00005004388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008259935,"about_ca_system_score_gemma":0.000151613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004185708,"about_ca_topic_score_gemma":0.000001173968,"domain_scores_codex":[0.9974762,0.0001260036,0.0005270552,0.0005942796,0.0006886122,0.0005878668],"domain_scores_gemma":[0.9985562,0.00007134659,0.0002016782,0.0006687286,0.0002288203,0.0002732503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000269383,0.0003014734,0.00009107868,0.00008843835,0.0001053958,0.000001356972,0.001024139,0.000001351369,0.9401222,0.000004469854,0.01538995,0.04260072],"study_design_scores_gemma":[0.00202628,0.0005365314,0.0007341963,0.0003014258,0.000116497,0.000001322432,0.0001971834,0.00007784574,0.9932344,0.00005651754,0.002462483,0.000255313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929794,0.0012721,0.00009326409,0.001952231,0.0001820116,0.0004509637,0.00006822337,0.00006622882,0.002935585],"genre_scores_gemma":[0.9922091,0.002921497,0.0009803593,0.0008713488,0.0001739601,0.00002845914,0.00005608327,0.0000386794,0.002720558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05311216,"threshold_uncertainty_score":0.9999987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064652673","doi":"10.1097/cad.0b013e32831c14ec","title":"Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Doxycycline; Cancer research; Internal medicine; Adenocarcinoma; Human breast; Medicine; Oncology; Breast cancer; Biology; Antibiotics; Cancer; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.01591470874108417,"gpt":0.2997624907008337,"spread":0.2838477819597495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007907888,0.0001948248,0.0002390807,0.00008294867,0.00005203797,0.00001647443,0.000202469,0.00008603882,0.0001265002],"category_scores_gemma":[6.265072e-7,0.0001788003,0.00008868857,0.000164065,0.00005757721,0.000008249827,0.00003190446,0.0001213853,0.000003396817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003742593,"about_ca_system_score_gemma":0.00007255561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000273537,"about_ca_topic_score_gemma":0.0002160402,"domain_scores_codex":[0.9989409,0.00002578446,0.0002627813,0.0003538785,0.0001418195,0.0002747981],"domain_scores_gemma":[0.99937,0.000004150283,0.0001428554,0.0003503046,0.00006959,0.0000631178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001350945,0.0002418112,0.001853261,0.00001781725,0.00008104164,0.000001890375,0.0002325342,0.00007987082,0.9871446,0.0001003788,0.000152138,0.009959542],"study_design_scores_gemma":[0.001601404,0.0003392262,0.01655523,0.00007902266,0.00004672973,0.00001264217,0.0001617001,0.00007223663,0.974087,0.0001020992,0.006683369,0.0002593407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972015,0.0006831535,0.0003553996,0.0004334518,0.0001409797,0.0002147718,0.0000507621,0.00001078976,0.0009092001],"genre_scores_gemma":[0.9967815,0.0006060591,0.0001310503,0.001149469,0.0001762088,0.00001843071,0.000047718,0.0000286937,0.00106088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01470197,"threshold_uncertainty_score":0.7291263,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2567819266","doi":"10.1097/cad.0000000000000469","title":"Effect of dihydroartemisinin on UHRF1 gene expression in human prostate cancer PC-3 cells","year":2017,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Artron Bioresearch (Canada)","funders":"Chongqing Municipal Education Commission","keywords":"DNMT1; Downregulation and upregulation; DNA methylation; Apoptosis; Cancer research; Cell cycle; Prostate cancer; Biology; Cancer cell; DNA methyltransferase; Methylation; Cancer; Molecular biology; Chemistry; Gene expression; Biochemistry; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.009098106776582633,"gpt":0.3157188842599165,"spread":0.3066207774833338,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003243799,0.0001772144,0.000240794,0.00004636624,0.0001516817,0.00003119215,0.0002556521,0.0001386802,0.00002443742],"category_scores_gemma":[0.0000219404,0.0001527651,0.00007936968,0.00003479759,0.00009031792,0.000007239877,0.0001075765,0.00009625882,0.000003360618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002110181,"about_ca_system_score_gemma":0.00004149284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003906569,"about_ca_topic_score_gemma":0.00007440524,"domain_scores_codex":[0.9988887,0.00009284701,0.0002403957,0.0003827933,0.000164284,0.0002310354],"domain_scores_gemma":[0.9990273,0.0000156491,0.000271022,0.0005868278,0.00004470522,0.0000545675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001025374,0.00004490872,0.03889016,0.00005957309,0.00001537502,0.000001279242,0.0001263696,0.0005638428,0.9518335,0.000002164305,0.0001640214,0.008196256],"study_design_scores_gemma":[0.001150099,0.0003596714,0.01006135,0.000139689,0.00001397191,6.036593e-8,0.000007361474,0.00003495184,0.9860536,0.00001859685,0.001988815,0.0001717933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968208,0.001677514,0.00001286306,0.0000727907,0.000250784,0.000285565,0.00005038088,0.000005084267,0.0008242276],"genre_scores_gemma":[0.9957761,0.002988084,0.00004363019,0.00003097808,0.0002002333,0.00007416368,0.00003918931,0.00002802512,0.0008195698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03422013,"threshold_uncertainty_score":0.6229581,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074635429","doi":"10.1097/cad.0b013e32831fb500","title":"Sorafenib tosylate in advanced kidney cancer: past, present and future","year":2009,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sorafenib; Medicine; Sunitinib; Kidney cancer; Oncology; Internal medicine; Cancer; Pharmacology; Clinical trial; Population; Hepatocellular carcinoma","retraction":null,"screen_n_in":null,"score":{"opus":0.0268176866030579,"gpt":0.3380587351365086,"spread":0.3112410485334507,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001525448,0.0008849124,0.00306222,0.0003497798,0.00007286075,0.00004269832,0.0002264944,0.0004594725,0.0002493788],"category_scores_gemma":[0.000005519193,0.0006568344,0.0004876257,0.0005879885,0.0000874465,0.0001307912,0.0001083499,0.0008015652,0.00003999771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007660861,"about_ca_system_score_gemma":0.001034293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005404354,"about_ca_topic_score_gemma":0.00003709768,"domain_scores_codex":[0.9967428,0.0001340046,0.0008335685,0.001074118,0.000497235,0.0007182641],"domain_scores_gemma":[0.9981697,0.00005641268,0.0004309417,0.0007416183,0.00009035208,0.0005109735],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006218745,0.0001473119,0.0003049749,0.01166997,0.0002982135,0.0002312185,0.0002289151,0.000002239721,0.000008216634,0.000007158535,0.0120295,0.9750101],"study_design_scores_gemma":[0.002062903,0.0001631399,0.0009472181,0.01835271,0.001470891,0.0000580876,0.00003883758,0.000004461132,0.0000790796,0.00001108862,0.9762565,0.0005550299],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00142425,0.9881216,4.888583e-7,0.005221721,0.0005880989,0.002389399,0.000165511,0.00007417276,0.002014769],"genre_scores_gemma":[0.0001299445,0.9898813,0.0001278851,0.0006902874,0.004169831,0.0006996028,0.0002362788,0.0001215514,0.003943356],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9744551,"threshold_uncertainty_score":0.9995883,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057651711","doi":"10.1097/cad.0b013e328350e835","title":"Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Doxorubicin; Cisplatin; Osteosarcoma; Methotrexate; Apoptosis; Cancer research; Chemotherapy; Pharmacology; Combination therapy; Medicine; Cytotoxic T cell; Chemistry; Immunology; In vitro; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01077270057721091,"gpt":0.2521662320645554,"spread":0.2413935314873444,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004374683,0.0003401251,0.0004689841,0.0001212809,0.00007792159,0.00003358176,0.0001720281,0.0002671747,0.00003993871],"category_scores_gemma":[0.00004307717,0.0003560552,0.00009192635,0.0002280372,0.0001529772,0.00004312762,0.0002387371,0.0002098712,0.00001569006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007577865,"about_ca_system_score_gemma":0.00007738233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005742535,"about_ca_topic_score_gemma":0.00003390459,"domain_scores_codex":[0.9979341,0.0001233998,0.0004355266,0.000607268,0.0003096093,0.0005900862],"domain_scores_gemma":[0.9990585,0.00004830946,0.0002384865,0.0003583992,0.0000896172,0.0002067043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008722374,0.0001964432,0.002868353,0.0000716626,0.0000525666,4.337591e-7,0.001712459,0.000008283176,0.9915667,0.00001002822,0.0001759763,0.003249858],"study_design_scores_gemma":[0.0008343903,0.0001150776,0.001833037,0.0001052521,0.00002581866,0.000001282262,0.0007734439,0.0000121253,0.9954233,0.000006079077,0.0004531693,0.000417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978545,0.0008415877,0.00004022924,0.0002234165,0.0002455313,0.0003785718,0.0001478972,0.00002220303,0.0002460929],"genre_scores_gemma":[0.9982424,0.0004491983,0.0004207002,0.0004989644,0.0002097819,0.00002864768,0.00003710392,0.00006178652,0.00005146011],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003856612,"threshold_uncertainty_score":0.9998891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2978014264","doi":"10.1097/cad.0000000000000653","title":"DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Triple-negative breast cancer; Immunotherapy; Breast cancer; Pharmacology; Metastatic breast cancer; Chemotherapy; Cancer; Cancer research; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03358925432978724,"gpt":0.3369031504235001,"spread":0.3033138960937128,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001932743,0.0003508182,0.0007374677,0.00009245209,0.0003001278,0.00005464748,0.0001593481,0.0001101248,0.0007551191],"category_scores_gemma":[0.0000168513,0.0001970744,0.0002049569,0.0003867257,0.0009712756,0.00009202993,0.00001918127,0.00008340012,0.000005864256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001707827,"about_ca_system_score_gemma":0.0005321138,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006879272,"about_ca_topic_score_gemma":0.0005821076,"domain_scores_codex":[0.9982521,0.00004183351,0.0004628415,0.000538666,0.000288647,0.0004159077],"domain_scores_gemma":[0.9985247,0.0002849394,0.0002235941,0.0004875743,0.0003608249,0.0001184182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06782123,0.002230691,0.08025618,0.0005443753,0.007489074,0.00001066592,0.03595867,0.000006704679,0.1918601,0.00004988798,0.0162577,0.5975147],"study_design_scores_gemma":[0.03674935,0.01182673,0.2893462,0.001410554,0.001353418,0.00006337891,0.002430548,0.0004724359,0.5001361,0.00003260749,0.1552751,0.0009035111],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9768506,0.006185541,0.000124619,0.01218632,0.0004695339,0.002951384,0.001069414,0.00004065619,0.0001218749],"genre_scores_gemma":[0.9813159,0.01083462,0.0005211091,0.001900213,0.0006799502,0.001313355,0.00001302678,0.00006759306,0.003354191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5966112,"threshold_uncertainty_score":0.999734,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062087170","doi":"10.1097/00001813-200411000-00003","title":"Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Genetics","keywords":"Efflux; P-glycoprotein; Paclitaxel; Peptide; Solubility; Glycoprotein; Chemistry; Vector (molecular biology); Biophysics; Pharmacology; Biochemistry; Internal medicine; Biology; Medicine; Organic chemistry; Multiple drug resistance; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01104076863687449,"gpt":0.2705038977552043,"spread":0.2594631291183299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003110797,0.0002818159,0.0006668672,0.00008298423,0.00009996759,0.00001444498,0.00008865238,0.0001450106,0.0001306918],"category_scores_gemma":[0.00001358379,0.0002290461,0.0001191147,0.0002030375,0.00039108,0.0001805624,0.0000126526,0.0002061399,0.000002639984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004110217,"about_ca_system_score_gemma":0.0002725336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001104438,"about_ca_topic_score_gemma":0.0007039455,"domain_scores_codex":[0.9982734,0.00002341494,0.0004624207,0.0005165564,0.0003505514,0.0003736577],"domain_scores_gemma":[0.999231,0.00004742901,0.000140185,0.0002853958,0.0001022973,0.0001937364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008814338,0.0008705906,0.1268182,0.004259021,0.0004626262,0.00008797531,0.004494683,0.00003675561,0.8429981,0.005321877,0.0001866714,0.01358203],"study_design_scores_gemma":[0.004535744,0.0005243833,0.3920099,0.0008483189,0.0002334798,0.00001515512,0.001379763,0.000008501561,0.5966815,0.001907415,0.001440872,0.0004149463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929056,0.002878583,0.0004147111,0.001918191,0.0001200379,0.000616182,0.00008098581,0.00006482196,0.001000939],"genre_scores_gemma":[0.9957045,0.002000517,0.0007603118,0.0002128127,0.0001119708,0.00005060533,0.00002704853,0.00003254061,0.001099736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2651916,"threshold_uncertainty_score":0.9340231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977936920","doi":"10.1097/00001813-200411000-00005","title":"G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells: caveolin-1 as a marker of cytotoxicity","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"","keywords":"Paclitaxel; Caveolin 1; A549 cell; Cytotoxicity; Cell cycle; Caveolae; Cytotoxic T cell; Apoptosis; Cancer research; Cell; Lung cancer; Cancer cell; Cell culture; Chemistry; Pharmacology; Cancer; Biology; Cell biology; Medicine; Internal medicine; In vitro; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.005456338230907018,"gpt":0.2644404624075181,"spread":0.258984124176611,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002516721,0.0004062891,0.0004835011,0.0001119028,0.0001073198,0.00003221831,0.0004256016,0.0004109674,0.0001855337],"category_scores_gemma":[0.00003713655,0.0003878021,0.0001897364,0.0003007289,0.0002077072,0.00002291357,0.0002225405,0.0002990118,0.000009381234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009993592,"about_ca_system_score_gemma":0.0005489126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00374571,"about_ca_topic_score_gemma":0.0005278319,"domain_scores_codex":[0.9976057,0.0000748095,0.0005725968,0.0007712202,0.0003704395,0.0006052031],"domain_scores_gemma":[0.9988359,0.00002133503,0.0003058868,0.0004976591,0.0001680963,0.0001711425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001710747,0.0002921569,0.005609939,0.000230292,0.000078718,0.000008805047,0.0005962249,0.0003816607,0.9904642,0.00001258868,0.001591221,0.0005631117],"study_design_scores_gemma":[0.001852716,0.00008729923,0.0007899683,0.0002964545,0.00004778334,0.000004814892,0.0003748924,0.00002562365,0.9921225,0.0001061606,0.003811336,0.000480435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812284,0.01644626,0.0001881943,0.0002874524,0.0002857246,0.0003875818,0.0002610864,0.00002145439,0.000893838],"genre_scores_gemma":[0.9864668,0.01072698,0.0001399411,0.0004982976,0.0003364733,0.0001597399,0.0001002037,0.00006263804,0.001508962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005719281,"threshold_uncertainty_score":0.9998574,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069340479","doi":"10.1097/cad.0b013e3280262427","title":"Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells","year":2007,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Gene expression profiling; Biology; Vinca; Gene; Gene expression; Topoisomerase; Computational biology; Drug; Microarray; Microarray analysis techniques; Cancer research; Pharmacology; Genetics; DNA","retraction":null,"screen_n_in":null,"score":{"opus":0.03234895651611599,"gpt":0.3474229593625183,"spread":0.3150740028464024,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008321556,0.0003505344,0.0005937663,0.0001985715,0.0001260768,0.00002196106,0.0004646907,0.0003655139,0.00003929637],"category_scores_gemma":[0.00002625853,0.0002479056,0.0003833984,0.0002748276,0.0001202455,0.000006310902,0.00007590461,0.0001656294,0.000002687882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007249609,"about_ca_system_score_gemma":0.0003921719,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004950719,"about_ca_topic_score_gemma":0.000004836773,"domain_scores_codex":[0.9979559,0.0002288207,0.0006717834,0.0006165355,0.0002361686,0.0002908464],"domain_scores_gemma":[0.9985194,0.00008584675,0.0006036483,0.0006221117,0.0001093107,0.00005970209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004514308,0.00008363638,0.0000179289,0.00131701,0.0001042645,2.840833e-7,0.0001213971,0.000006257127,0.8253995,0.000003290034,0.01136461,0.1611304],"study_design_scores_gemma":[0.0004209223,0.00005641683,0.00004669948,0.001145719,0.0000582675,7.818431e-7,0.00009307885,0.000003234644,0.4953189,0.000003820729,0.5027131,0.0001389804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01917276,0.9775513,0.0003520513,0.0001032203,0.0004793395,0.001912299,0.0002935081,0.00001633349,0.0001191541],"genre_scores_gemma":[0.009725203,0.9865681,0.0001820414,0.00009264627,0.0003863508,0.0008174085,0.0003549019,0.00007794253,0.001795408],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4913485,"threshold_uncertainty_score":0.9999973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058595915","doi":"10.1097/00001813-200112004-00003","title":"Maximizing the response to Herceptin® therapy through optimal use and patient selection","year":2001,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Immunohistochemistry; Medicine; Concordance; Oncology; Breast cancer; Trastuzumab; Metastatic breast cancer; Internal medicine; Targeted therapy; Cancer; Disease; Fluorescence in situ hybridization; Gene; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1727720393999385,"gpt":0.4460614837562243,"spread":0.2732894443562859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008420337,0.0005864025,0.001482267,0.0002377915,0.0003068845,0.0002139531,0.0003067367,0.0003411278,0.0006119823],"category_scores_gemma":[0.0001875573,0.0003741118,0.0003569628,0.001295144,0.0001826151,0.0001978004,0.0001934881,0.001120393,0.0001281742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007511907,"about_ca_system_score_gemma":0.001054216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001329531,"about_ca_topic_score_gemma":0.00002602349,"domain_scores_codex":[0.9960467,0.0007814813,0.0006679043,0.0008838049,0.0008394052,0.0007807594],"domain_scores_gemma":[0.9978834,0.0005897749,0.000242819,0.0007723544,0.0002689068,0.0002427188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006645375,0.00008119849,0.0001446259,0.001429354,0.0002608382,0.00002993592,0.002177771,0.000008980207,0.00005548852,0.000005423769,0.01197786,0.983164],"study_design_scores_gemma":[0.0006280463,0.0005447843,0.0001783065,0.007664186,0.0002315172,0.0001438874,0.0002749382,0.00001091897,0.00009158802,0.000002358993,0.9898449,0.0003845227],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01882774,0.9748539,0.00004529744,0.002119873,0.0003444452,0.003248486,0.00005468568,0.0001035331,0.0004020002],"genre_scores_gemma":[0.000341002,0.9930012,0.0008608064,0.001901197,0.0005516855,0.0008809076,0.00001867359,0.0001813067,0.002263178],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9827794,"threshold_uncertainty_score":0.9998711,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2592985951","doi":"10.1097/cad.0000000000000493","title":"A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Eribulin; Capecitabine; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Clinical trial; Confidence interval; Retrospective cohort study; Cancer; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.04661719267652718,"gpt":0.4187347429406821,"spread":0.3721175502641549,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004717512,0.0004637361,0.01063775,0.0005953316,0.00003823652,0.00001062695,0.0002053248,0.0001259778,0.0006369731],"category_scores_gemma":[0.00005492492,0.0003265738,0.0008627446,0.00109184,0.000228672,0.0001020766,0.00007449739,0.0002574845,0.000002712371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003666506,"about_ca_system_score_gemma":0.0006727533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002355473,"about_ca_topic_score_gemma":0.0007987909,"domain_scores_codex":[0.9973068,0.0002582861,0.001414485,0.0004861,0.0002753898,0.0002589655],"domain_scores_gemma":[0.9968247,0.0001209895,0.002092423,0.0006256526,0.0002456136,0.0000905765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00004205165,0.0001764624,0.001197666,0.9533989,0.03092316,0.00002001339,0.0002296466,4.37096e-7,0.000003614066,0.00002274019,0.0001768731,0.01380839],"study_design_scores_gemma":[0.001003048,0.0001072202,0.001973781,0.5554119,0.4347702,0.00003945675,0.00003764942,0.000005617614,0.00001096687,0.00000499524,0.006345112,0.0002900145],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002944937,0.994375,4.886851e-7,0.0002856364,0.0001023682,0.002810996,0.001972235,0.00001028898,0.0001485232],"genre_scores_gemma":[0.001471499,0.9959885,0.00001779213,0.0001038534,0.0000424619,0.001076235,0.0001280842,0.00003866992,0.001132943],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.403847,"threshold_uncertainty_score":0.9999186,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2936620117","doi":"10.1097/cad.0000000000000685","title":"Cannabis-related cognitive impairment","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cannabis; Neurocognitive; Medicine; Psychiatry; Cognition; Anxiety; Effects of cannabis; Depression (economics); Effects of sleep deprivation on cognitive performance; Clinical psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.01320752456545791,"gpt":0.3263477358163184,"spread":0.3131402112508604,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002759621,0.00021603,0.0003547317,0.0001699127,0.0001972723,0.00003916844,0.0001256223,0.0001269555,0.005471856],"category_scores_gemma":[0.00004213172,0.0001785692,0.0001682554,0.0005303955,0.0004777878,0.00009560429,0.00009719037,0.0003130466,0.0006647976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000205349,"about_ca_system_score_gemma":0.0006044864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001500867,"about_ca_topic_score_gemma":0.00008122728,"domain_scores_codex":[0.9980023,0.00004649671,0.0002984331,0.0004579895,0.0005594661,0.0006353284],"domain_scores_gemma":[0.9986495,0.000006599781,0.00007912974,0.0003064211,0.000625266,0.0003330305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007034914,0.000696682,0.02772871,0.0002090351,0.0005461628,0.00009839454,0.004604858,0.000001078846,0.01307804,0.0003809862,0.8923014,0.0596512],"study_design_scores_gemma":[0.01003086,0.002325595,0.2995266,0.0007206603,0.0003726317,0.0001060511,0.003253965,0.0004515668,0.1729069,0.0001794867,0.5093263,0.000799402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9488288,0.0007738439,0.00001210677,0.02166346,0.0004667497,0.0007348545,0.00005460397,0.0001156591,0.0273499],"genre_scores_gemma":[0.8916419,0.0002886897,0.00001541775,0.002210855,0.0006181687,0.000155374,0.00003138247,0.00004480818,0.1049934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3829751,"threshold_uncertainty_score":0.9954373,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2080071903","doi":"10.1097/01.cad.0000203388.68034.06","title":"Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Laminin; MAPK/ERK pathway; Protein kinase A; Biology; Molecular biology; Cell growth; Cell adhesion; Cell biology; Cell surface receptor; Kinase; Extracellular; Extracellular matrix; Cell; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.008405670631498089,"gpt":0.2313227782179116,"spread":0.2229171075864135,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003345883,0.0002235966,0.0002412914,0.00002890013,0.0001420058,0.00003272961,0.0001637049,0.000123479,0.0000895416],"category_scores_gemma":[0.00001738054,0.0001856566,0.0001325896,0.0001429237,0.0001227115,0.00001978624,0.00007463825,0.000118478,0.00001647955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002259222,"about_ca_system_score_gemma":0.00008753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005496874,"about_ca_topic_score_gemma":0.00002056557,"domain_scores_codex":[0.998503,0.0001553192,0.0003936764,0.000397423,0.0002452177,0.0003053703],"domain_scores_gemma":[0.9991725,0.00002420141,0.0003053854,0.0003155144,0.0001364171,0.00004596636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003984652,0.00009073439,0.0001833051,0.0000621615,0.00002791104,7.773622e-7,0.00009878652,0.0003019178,0.9858828,0.00003783119,0.0130963,0.0001776067],"study_design_scores_gemma":[0.0007171631,0.0001477975,0.00005252435,0.00008617296,0.00004177276,0.000001426745,0.0002998793,0.000114462,0.9941806,0.0001559828,0.00396447,0.0002377041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943372,0.002068831,0.00202697,0.0002559142,0.0001910522,0.0003416926,0.000172589,0.00002240986,0.0005833388],"genre_scores_gemma":[0.9965941,0.0006106698,0.0006943276,0.0002049585,0.0002974462,0.00003376227,0.0005161637,0.00003852414,0.001010037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009131829,"threshold_uncertainty_score":0.7570854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2333316232","doi":"10.1097/cad.0b013e32834ea5b3","title":"Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Sorafenib; Clonogenic assay; Cancer research; Medicine; Annexin; Vascular endothelial growth factor; MAPK/ERK pathway; Apoptosis; Radiation therapy; In vivo; Cancer; Internal medicine; Pharmacology; Oncology; Hepatocellular carcinoma; Kinase; Biology; Immunology; VEGF receptors; Flow cytometry","retraction":null,"screen_n_in":null,"score":{"opus":0.0206076060221092,"gpt":0.2677900791661434,"spread":0.2471824731440342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001989982,0.0001976156,0.0002199456,0.0001042529,0.00007099049,0.00003344919,0.000109951,0.0001402331,0.00002677618],"category_scores_gemma":[0.000002745114,0.0001758473,0.00006127181,0.0002240399,0.00006242394,0.00004850147,0.00004795832,0.0001037603,0.000003583991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001374396,"about_ca_system_score_gemma":0.0001901712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001521978,"about_ca_topic_score_gemma":0.0004631015,"domain_scores_codex":[0.9988598,0.00005455553,0.0001770697,0.0003397769,0.0001576754,0.0004111801],"domain_scores_gemma":[0.999561,0.000005009177,0.0001178796,0.0001847835,0.00006426877,0.0000670629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000172216,0.0002160874,0.6657162,0.00003509072,0.00004047462,0.000001178982,0.0006730641,0.004846164,0.3206102,0.00002626429,0.0003248827,0.007338122],"study_design_scores_gemma":[0.002368698,0.00003825467,0.6860006,0.000113496,0.00003132349,0.000005957421,0.0001297202,0.007735693,0.3025185,0.00001148604,0.0006239683,0.0004223561],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962121,0.001498909,0.0006404101,0.001135282,0.0001266534,0.0002237009,0.00005279712,0.00001086257,0.00009923837],"genre_scores_gemma":[0.9975791,0.001491616,0.00007799244,0.000266115,0.000235249,0.0001707596,0.0000329451,0.00003547903,0.0001107293],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02028437,"threshold_uncertainty_score":0.7170846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011446012","doi":"10.1097/cad.0b013e3280115fe8","title":"Type II combi-molecules: design and binary targeting properties of the novel triazolinium-containing molecules JDD36 and JDE05","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre; Royal Victoria Regional Health Centre; Health Canada; Royal Victoria Hospital","funders":"","keywords":"Epidermal growth factor receptor; Epidermal growth factor; Tyrosine kinase; Biology; Growth factor receptor; Molecular biology; DU145; Comet assay; Receptor; A431 cells; LNCaP; DNA damage; Chemistry; Cancer research; Cell biology; Biochemistry; Cancer cell; Cell; DNA; Cancer; Cell cycle","retraction":null,"screen_n_in":null,"score":{"opus":0.01888690628887627,"gpt":0.2368112892721645,"spread":0.2179243829832882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000172701,0.0001692329,0.0001971385,0.00003236125,0.0001694398,0.00002609824,0.0001646639,0.0001055268,0.000004935971],"category_scores_gemma":[0.00003686514,0.0001230319,0.00005611316,0.00008789395,0.0002010693,0.000009284967,0.0002176928,0.00008739141,6.875916e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006721765,"about_ca_system_score_gemma":0.00009148256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003143654,"about_ca_topic_score_gemma":0.0000121168,"domain_scores_codex":[0.9990793,0.00005578217,0.000246888,0.0003032707,0.0001055773,0.0002091719],"domain_scores_gemma":[0.999508,0.00001423278,0.0001339962,0.0001946059,0.0001182357,0.00003089789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001759955,0.00005083661,0.002087145,0.0000368236,0.00004555577,6.204264e-7,0.00023345,0.0003728707,0.9956366,0.00004587947,0.0007548835,0.0005593168],"study_design_scores_gemma":[0.0008000873,0.0003465271,0.001882532,0.0001081113,0.00004225575,0.000005533646,0.0004412183,0.000902041,0.9936973,0.00002604767,0.001537043,0.0002112536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895168,0.009137196,0.0005708647,0.0002076056,0.0001521368,0.0001968868,0.00001163938,0.000008606222,0.000198274],"genre_scores_gemma":[0.9976277,0.001128308,0.0005486638,0.0002503647,0.0001163919,0.00001614053,0.00001315254,0.00002093483,0.0002783565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008110897,"threshold_uncertainty_score":0.5017094,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}